IFF to Full Merger With DuPont’s Nutrition & Biosciences Organization
NEW YORK–(Business enterprise WIRE)–Feb 1, 2021– IFF (NYSE: IFF) to entire the previously declared merger
NEW YORK–(Business enterprise WIRE)–Feb 1, 2021– IFF (NYSE: IFF) to entire the previously declared merger
Third Quarter Net Revenue of $8.2 Million Up 7% vs Prior Year; Third Quarter Year
PARSIPPANY, NJ, Jan. 20, 2021 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today
SOUTH SAN FRANCISCO, Calif.–(Small business WIRE)–Jan 19, 2021– Imago BioSciences, Inc. (Imago), a clinical phase
Acquired Scientific Demo Authorization to Begin Most cancers Urge for food Recovery Phase I/II Scientific
Received Scientific Demo Authorization to Commence Cancer Appetite Recovery Period I/II Clinical Research of Art27.13